Cargando…
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
OBJECTIVES: To characterize the relationship between serum medroxyprogesterone acetate (MPA) concentrations and ovulation suppression, and to estimate the risk of ovulation for investigational subcutaneous regimens of Depo-Provera CI (Depo-Provera) and Depo-subQ Provera 104 (Depo-subQ). STUDY DESIGN...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907671/ https://www.ncbi.nlm.nih.gov/pubmed/35281554 http://dx.doi.org/10.1016/j.conx.2022.100073 |